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Abstract 
As the leading cause of death and disability in individuals under the age of 45-years-old, 
Traumatic Brain Injury (TBI) is a public health crisis that demands the attention of the 
scientific and medical community [28]. The majority of all TBIs that occur in the United 
States each year are a non-deadly yet detrimental form of closed brain injury known as 
mild TBI (mTBI) or concussion [6]. Athletes, young people and military personnel all face 
a high risk of acquiring mTBI as a result of their environments. In our study we have 
chosen to model repeated mTBI (rmTBI) in the mouse in order to gain a boarder 
understanding of the mechanisms of injury and cellular changes occurring immediately 
after and months following rmTBI. Over a 3-month time course, we observed a gradual, 
yet significant, increase in lateral ventricular volume in mice that had induced rmTBI over 
that of control mice. In addition we observed changes in microglial morphology and 
activation throughout the brain immediately after rmTBI and up through 3-months 
following injury. Both of our findings contribute to the hypothesis that sustaining repeated 
rmTBIs over time can lead to an increased risk for neurodegeneration or poor recovery.  
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Introduction 
Traumatic brain injury (TBI), an acquired injury resulting from a rapid and sudden 
blow to the head, is a serious health concern. The CDC estimates that on average 1.7 
million people sustain a TBI each year, costing the United States approximately 76.5 
billion dollars in direct and indirect medical costs annually [6]. Traumatic brain injury can 
potentially leave fully functioning individuals handicapped or impaired with little hope for 
recovery, putting strain on family and caregivers.  Young adults, athletes, and military 
personnel make up a large group of people routinely diagnosed with a non-deadly yet 
symptomatically significant form of TBI known as mild TBI (mTBI) [3] [6]. 
Improvements have been made in identifying patients with concussions or mTBI, however 
treatment options are limited, and little is known about the long-term effects of physical 
injury to the brain or the brains capacity for recovery [17]. Physical symptoms of mTBI 
including headache, dizziness, or memory loss often disappear within a few weeks of the 
injury [5]. Sustaining repeated mTBI (rmTBI), however, may lead to Chronic Traumatic 
Encephalopathy (CTE), a severe neurodegenerative disease characterized by diffuse 
accumulations of hyperphosphorylated tau throughout the brain. Patients diagnosed 
posthumously with CTE have been as young as 17-years-old [3] [21] [26]; however, the 
usual age of onset is between 40 and 50 years old. Serious	   cognitive	   decline,	   short-­‐term	   memory	   loss,	   personality	   changes,	  aggression,	   and	   suicidal	   thoughts	   are	   all	   symptoms	   associated	  with	   CTE.	   Advanced	  forms	   of	   CTE	   may	   be	   misdiagnosed	   as	   other	   neurodegenerative	   diseases	   such	   as	  Alzheimer’s	   disease	   or	   even	   Parkinson’s	   disease,	   as	   the	   clinical	   presentations	   are	  similar	   [21].	   CTE	  patients	   however,	   rarely	   present	  with	   amyloid-­‐β	   plaques,	   and	   the	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tau	   pathology	   found	   in	   CTE	   is	   distinct	   from	   that	   seen	   in	   Alzheimer’s	   disease.	  Neurofibullary	   Tau	   tangles	   are	   usually	   distributed	   in	   the	   frontal	   and	   temporal	  cortices	   in	   close	   contact	  with	   cerebral	  vesicles	  or	   in	   the	   cerebral	   sulci.	  A	  CTE	  brain	  shows	   pronounced	   atrophy	   in	   the	   cerebral	   cortex,	   medial	   temporal	   lobe	   and	  diencephalon,	  and	  distinctly	  enlarged	  lateral	  ventricles	  [13] [21].	  	  The	   association	   of	   ventriculomegaly	   with	   CTE	   was	   what	   initially	   drew	   the	  Conover	   lab	   to	  study	  mTBI	   in	  a	  mouse	  model.	  The	  Conover	   lab	   focuses	  research	  on	  neurogenesis	  of	   the	  mammalian	  Subventricular	  Zone	   (SVZ),	   a	   region	   that	   lies	   along	  the	  lateral	  walls	  of	  the	  lateral	  ventricles	  [20].	  The	  SVZ	  is	  one	  of	  two	  neural	  stem	  cell	  niches	  that	  persists	   into	  adulthood,	  however	   in	  response	  to	  stressors	  such	  as	  aging,	  the	  SVZ	  tends	  to	  show	  deterioration	  [28].	  The	  SVZ	  is	  a	  highly	  organized	  network	  made	  up	  of	   four	  distinct	  cell	   types:	  ependymal	  cells,	  SVZ	  astrocytes,	   transitory	  amplifying	  cells,	  progenitor cells, and neuroblasts [20] and [25].  In the adult SVZ, proliferating radial 
glia cells (astrocytes) generate transient amplifying cells, which in turn give rise to 
neuroblasts. In the rostral migratory stream (RMS), a chain of neuroblasts from the SVZ 
migrates though tubes of astrocytes towards the olfactory bulb. Once the neuroblasts have 
reached the core of the olfactory bulb the immature neurons disengage from the RMS to 
differentiate into cells required for olfactory function [22]. Ependymal cells are simple 
ciliated epithelial cells that line the interior walls of the lateral ventricles. Junctions connect 
the ependymal cells together at the apical end of the cell, creating an interface between the 
interior of the ventricles and the rest of the brain [5].   The structure and enzymatic output 
of ependymal cells creates a barrier between the cerebrospinal fluid (CSF) and the brain 
parenchyma and assists in cerebral fluid balance, toxin metabolism and secretion. The 
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ependymal lining may also serve to protect the SVZ stem cell niche. Damaged ependymal 
cells are typically replaced by astrocytes, which form a glial scar. The glial scar has a 
similar morphology to the ependymal cell, however it does not contain the same cilia or 
protein channels that may assist in creating the CSF-brain barrier [5]. 
Stem cells and neuroblasts residing in the SVZ may be a potential source of new 
cells for neural tissue repair after mTBI. Following experimentally induced ischemic 
stroke in rats, several studies have shown neuroblasts from the SVZ migrate to the site of 
injury [17]. The majority of migrating neuroblasts that reach injured stroke regions usually 
remain undifferentiated, and those neuroblasts that do differentiate typically die, as they 
are unable to integrate into mature neuronal networks. An increase in neurogenesis in the 
SVZ has been shown in mouse models with induced TBI, however determining the fate of 
differentiated cells and their migratory patterns remains a challenge [17]. Although there is 
significant interest within the scientific community in neural repair, little is actually 
understood about how a single mTBI or multiple rmTBI might alter or change the neural 
stem cell niche.   The initial aim of our rmTBI study was to determine whether any 
changes in ventricular volume could be observed over a 3-month period following rmTBI 
in mice. The gross ventriculomegaly seen in human CTE patients led us to hypothesize that 
rmTBI would result in an increase in the ventricular volume and an increase in glial 
scarring along the ependymal lining [28]. Damage to the lateral wall may directly impact 
the brain’s response to physical injury and capacity for regeneration.  
Recent studies have shown that microglia, the brain’s resident immune cells, also 
play a role in SVZ neurogenesis [17] [29]. Microglia are responsible for surveying the 
brain for areas of damage, and are known to exhibit distinct changes in cellular 
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morphology and physiology in response to neuronal injury or infection [2], [18] and [23]. 
A healthy brain contains as many microglia as it does neurons [2]. In the resting state, 
microglia are identified as “ramified” with characteristically small cellular bodies and 
numerous thin processes extending out from the soma [18]. While the fine processes of 
ramified microglia are continuously moving in order to probe their environment, the soma 
remains relatively still [18]. Ramified microglia are rarely seen touching one another; 
however, they are often found in direct contact with astrocytes or neurons [2]. Microglia 
become “activated” in response to minute alterations in brain chemistry, including 
extracellular ATP, cytokines, necrotic tissue and neurotransmitters [18] [23]. Receptors on 
the surface of microglial membranes bind to such molecules, and signal for the cell to 
undergo a complex set of phenotypic changes, transforming into an “activated microglia.” 
Activated microglia take on a macrophage-like morphology, migrate towards sites of 
injury or infection, secrete numerous cytokines, phagocytose dead cells or debris and 
proliferate [18] [23]. An activated microglia will upregulate the expression of Iba-1, a 
cytoplasmic protein not expressed in any other neuronal cells, making it an ideal target for 
immunohistochemical assays [8]. 
Microglia take on one of two distinct subtypes following activation, M1 or M2 [8]. 
The M1 cells are characterized as having a proinflammatory profile, producing high levels 
of interferon-gamma (IFN-γ), tumor necrosis factor (TNF-α), interleukin-1β (IL-1β), IL-
12 [7] [11]. M2 microglia act in opposition to M1 cells by dampening inflammation 
through the release of anti-inflammatory cytokines including IL-10 and transforming 
growth factor (TGF)-β. M2 cells also contribute to brain recovery by phagocytosing 
cellular debris [11]. 
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  During early postnatal development microglia are found in semi-activated states 
concentrated in the two neurogenic regions of the brain, the SVZ and the hippocampus [9]. 
The cytokines released by partially activated microglia have been shown to play a role in 
proliferation within the SVZ niche [27]. The function of microglia in neurogenesis is still 
not fully understood, however many studies illustrate a beneficial role for partially 
activated microglia in neurogenic environments during development or after injury [29]. 
When mTBI occurs, lateral acceleration and deceleration of the brain within the 
skull causes primary mechanical damage, resulting in the shearing of neurons, glia and 
blood vessels along with stretching of epithelial tissue [19]. The physical damage to tissue 
and breakdown of membranes leads to what is known as secondary injury, where 
neurotransmitters, ions and free radicals escape from dying cells inducing 
neuroinflammation and apoptosis [19] [30]. Responding to the accumulation of 
neurochemical molecules in the extracellular space, microglia become activated, taking on 
the M1 subtype, releasing pro-inflammatory cytokines, nitric oxide and reactive oxygen 
species into their environment [11]. The M1 proinflammatory cascade is important for the 
initiation of the immune response within the brain; however, if left unbalanced by the M2 
anti-inflammatory process individuals may experience lasting mTBI symptoms or poor 
recovery. Repeatedly exposing the brain to mechanical injury as seen in athletes with 
rmTBI, may prevent microglial subpopulations from transitioning into M2 subtypes, 
leading to prolonged neuroinflammation and an increased risk for neurodegeneration [7].  
The second aim of this study was to characterize morphological changes in 
microglia in mice following rmTBI. Coronal sections of brain regions susceptible to mTBI 
including the lateral ventricles, hippocampus, corpus callosum, and cortex were analyzed 
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via immunohistochemistry immediately following rmTBI and 3 months after injury.  
While other groups have shown mTBI can activate microglia, our study indicates that 
repeated head trauma in mice results in a sustained proinflammatory profile up to three 
months following injury. We hypothesize that these findings have broad implications for 
rmTBI recovery and the progression of neurodegeneration following rmTBI. 
Understanding the neuroinflammatory process and timeline may help researchers design 
successful therapeutic drugs or implement better return to play policies to avoid further 
injury [19].  
 
Methods 
Currently, neuroimaging techniques, such as MRI, are the best ways to study 
rmTBI in living humans. While there have been significant advances in radiology over the 
past decade, the imaging technology does not yet exist to view changes occurring within 
cells. In addition the costs of operating advanced MRI machines and collecting large pools 
of data is very expensive. This leaves post-mortem tissue analysis as the only method to 
study human rmTBI related brain changes at the microscopic level. When researchers 
examine post-mortem tissue of individuals known to have sustained multiple mTBIs 
throughout life, neurodegeneration is often advanced. It may also be challenging to 
distinguish age-related changes from those caused by rmTBI.  A mouse model provides an 
opportunity to study the effects of rmTBI at various intervals following injury. A large 
body of literature indicates numerous animal models have already been developed to study 
TBI [10] [14] [30]; however, few models exist that accurately replicate the kind of 
repeated mild concussive injury an athlete may sustain on the playing field. The severity of 
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any TBI is highly dependent on how and where the individual was hit on the head, as well 
as their age, gender, and genetics [30]. The mouse model allows many of these variables to 
be controlled for, allowing us to develop a more generalized and simplified understanding 
of the primary and secondary injuries that occur following rmTBI.  Models such as the 
fluid percussion injury (FPI) require the researcher to perform a craniotomy over the 
midline or parietal bone of the mouse, before a fluid pressure pulse is delivered directly to 
the dura, displacing the brain to induce injury to the tissue [30]. While this method can 
replicate the intracranial hemorrhage and neural swelling seen in human TBI, it is 
unrealistic and does not mimic any injury a human patient might ever sustain. The 
craniotomy also places the animal at an increased risk of infection, which could alter 
studies of microglial activation.  
 In 2012, Kane et al. developed a unique mouse model to specifically study rmTBI. 
Their model can accurately induce repeated mild concussive injuries over time and 
includes features that allow for free movement of the animal’s head and torso during rapid 
acceleration and deceleration. Even after multiple hits to the head, skull fractures and 
intracranial bleeding are rarely observed in their mice [14].  We selected this effective and 
uncomplicated model for our studies of rmTBI on the lateral ventricles, SVZ and 
microglial activation.  
The apparatus used by Kane et al to induce rmTBI is depicted in figure 1 [14]. Two 
Plexiglas pieces (15cm length x 9 cm width x 23 cm depth) make up the frame of the 
apparatus. An aluminum foil sheet is used to create a bridge across the top of the Plexiglas 
frame. A sponge cushion (15 cm x 9 cm x 13 cm) is placed 10 cm below the aluminum foil 
bridge. After being anesthetized with isoflurane, the mouse is placed on the aluminum foil 
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bridge with its head directly under a PVC guide tube (20 mm diameter x 1.5 m length). A 
95g solid brass weight is released 40 mm from the bottom of the PVC tube, and falls 
directly onto the midline of the mouse’s head between the ears. When the weight makes 
contact with the mouse the aluminum foil sheet tears apart, allowing the mouse to free fall 
and perform a 1800 flip. The mouse will land supine on the cushion 10 cm below the initial 
resting point.  Sham control mice receive the same dose of isoflurane as experimental mice 
and are positioned on the apparatus, but do not receive an impact or fall through the 
aluminum foil bridge.  
 
 
 
 
  
 
 
 
 
 
 
We designed two different rmTBI studies (Figure 2) that were carried out on the 
Kane et al. group’s apparatus at Wayne State University [14]. In the first study C57 mice 
received five hits with a 95 g weight over three days, with hits being carried out in the 
morning and the evening. Following the fifth hit, mice received an injection of 
Figure	   1.	   rmTBI	   apparatus	   (A)	   The	  entire	  apparatus	  including	  the	  (20	  mm	  x	   1.5	   m)	   PVC	   delivery	   tube	   and	  plexiglas	   frame.	   (B)	   Aluminum	   foil	  bridge	   is	   pictured	   over	   the	   Plexiglas	  frame.	   (C)	  The	  mouse	   is	   shown	   in	   the	  initial	   position	   with	   head	   directly	  below	   the	   PCV	   delivery	   tube.	   (D)	  Following	  impact	  with	  95	  g	  weight	  the	  mouse	   breaks	   through	   the	   aluminum	  foil	   bridge,	   completes	   1800	   flip	   falling	  onto	  the	  cushion	  10	  cm	  below	  [14].	  	  
Talbot,	  12	  
bromodeoxyuridine (BrdU) to mark cells undergoing DNA replication. Mice were then 
sacrificed at four time points following the last impact: 2-hours, 2-weeks, 1-month and 
three-months post injury. In our second study mice received an initial five hits over 3 days, 
then underwent a resting period of two weeks. Following the resting period experimental 
mice were subjected to an additional round of five hits over three days then a BrdU 
injection immediately after the last impact. Mice from the second study were sacrificed at 
three time points after the final injury: 2-hours, 1-month and 3-months following injury.  
 
 
 
 
 
 
 
 
 
 
 
 
Researchers from Wayne State University were responsible for inducing rmTBI 
and sacrificing mice according to the established time line (Figure 2). Mice were scarified 
via cardiac perfusion with saline and 4% PFA followed by excision of the entire brain. 
Figure	   2.	   	   rmTBI	   study	   outline	   (A)	  Depicts	   the	   outline	   for	   the	   initial	   rmTBI	   used	   to	  complete	   ventricular	   volume	   assessments.	   (B)	   Shows	   the	   second	   rmTBI	   study	   outline	  employed	  in	  the	  microglial	  activation	  studies.	  	  
A	  
B	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Brains were shipped in PBS to University of Connecticut where members of the Conover 
Lab carried out all further analysis.  
Immunohistochemistry  
Control and experimental brains were processed and analyzed using the same 
methodology. For both the ventricular volume analysis and microglial activation study, 
brains were embedded in agarose, mounted on a virbratome (VT-1000S; Leica), and then 
sectioned into 50 μm coronal slices. Sections were blocked in 10% Horse Serum 
(Invitrogen) in PBS/0.1%Triton X-100 for one hour. For the ventricular volume studies, 
brains were then incubated with rat anti-BrdU, mouse anti-GFAP (Abcam) and goat anti-
Aquaporin-4 primary antibodies. The BrdU antibody marks cells that underwent division 
at the time of the IP BrdU injection. GFAP (Glial Fibrillary Acidic Protein) is a marker for 
reactive astrocytes, and Aquaporin-4 (AQP4) marks water channels located on the basal-
lateral membrane of ependymal cells. Before applying the BrdU primary antibody the 
sections were acid-fast treated.  
For the microglial activation study rat anti-GFAP (Abcam), rabbit anti-Iba-1 
(Wako) and mouse anti-Doublecortin (Abcam) were used as primary antibodies. Iba-1 is 
an intracellular calcium binding protein that is highly expressed in activated microglia, and 
doublecortin (DCX) is a marker for neuroblasts. 
After 24 hours incubation with primary antibodies at 4oC, sections were rinsed 
three times in PBS before the addition of corresponding Alexa Fluor dye-conjugated 
secondary antibodies (Invitrogen) to the tissue for 1 hour at room temperature. Following 
secondary antibody removal the tissue was rinsed two times, DAPI nuclear stain was 
added to the tissue, then all sections were rinsed 3 additional times in PBS. Sections were 
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mounted onto glass slides then coverslipped with Aqua-Poly/Mount (Polysciences) and 
allowed to dry completely.  
Ventricular Volume  
To determine the volume of the lateral ventricles in control and rmTBI mice, the 
lateral ventricles were viewed on a Carl Zeiss Axio Imager M2 Microscope with Apotome 
(Carl Zeiss) at 10x then traced using StereoInvestigator software. Approximately 38 50μM 
sections were traced to make up the entire lateral ventricle. Following tracing the sections 
were uploaded and stacked in the program Neurolucida Explorer, to create a 3-D model of 
the lateral ventricles.  Once the 3-D model was complete, the software was able to 
calculate consistently accurate ventricular volumes. Figure 3 depicts stacked lateral 
ventricle sections and a 3-D reconstruction of the brain and lateral ventricles. A students t-
test p<.05, was performed on volume data and SEM error bars were added.  
 
Imaging of Microglia 
Following immunohistochemical preparation, Iba-1+ microglia were imaged at 10x 
on the Carl Zeiss Axio Imager M2 Microscope with Apotome (Carl Zeiss) using 
Figure	  3.	  	  Lateral	  Ventricle	  Tracing	  and	  3D	  Reconstruction	  Stacked	  lateral	  ventricles	  from	  a	  
(A)	   control	   mouse	   and	   (B)	   rmTBI	   mouse	   in	   the	   Neurolucida	   Explorer	   program.	   (C)	   3-­‐D	  reconstruction	   of	   stacked	   coronal	   showing	   the	   lateral	   ventricles	   and	   whole	   brain.	   Lateral	  ventricle	  volumes	  were	  calculated	  from	  3-­‐D	  reconstruction.	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Hamamatsu ORCA-R2 digital camera C10600 and at 40x on a Leica TCS SP2 confocal 
laserscan microscope. The gain and light exposure were kept constant throughout all 
imaging.  
Results  
Expansion in the lateral ventricles following rmTBI 
Reconstruction of the lateral ventricles from mice in the initial rmTBI study 
revealed a gradual increase in lateral ventricular volume during a 3-month interval in 
rmTBI mice over control mice. We noticed the greatest volume expansion in 3-month mice 
and a slight decrease in volume from the 2-week to 1-month time points.  
Microglial Activation Following rmTBI  
Figure	   4.	   Lateral	   ventricular	   volume	   expands	   after	   rmTBI.	   Immediately	   following	  the	  5	  hits	  over	  3	  days	  rmTBI	  model,	  mice	  experience	  ventricular	  expansion.	  The	  lateral	  ventricles	   continued	   to	   expand	  over	   the	   course	  of	   the	  3-­‐month	   interval	   to	   the	  highest	  volume	  recorded.	  All	  four	  experimental	  groups	  show	  significance	  over	  control	  (*p<0.05,	  students	  t-­‐test,	  SEM	  error	  Bars).	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Four brain regions were selected to examine the effect of rmTBI on microglial activation. 
The lateral ventricles were selected due their close association with the neurogenic SVZ 
niche. The hippocampus was examined next as it is the other site of neurogenesis in the 
brain. The corpus callosum was chosen for analysis, as it is made up of long white matter 
tracts, which are highly susceptible to tearing as a result of the lateral 
acceleration/deceleration and torsional brain movement occurring during rmTBI. Microglia 
in the cortex by the site of impact were also analyzed for changes in morphology.  
Changes in microglia morphology and activation varied in different brain regions 
and was altered over time. Along the border of the lateral ventricles (Figure 5), an increase 
in soma size can be observed in mice sacrificed 2-hours following rmTBI. Both increases 
in soma size and cell process thickness are noticeable in rmTBI mice 3-months after injury. 
In the hippocampus the rmTBI mice sacrificed 3-months after injury had more microglia 
with larger cell bodies and thicker processes than 2-hour rmTBI mice or either control 
mouse.  In the corpus callosum microglia appear more frequently in the activated 
phenotype 2-hours after rmTBI than any other group. Within the cortex of rmTBI mice 
sacrificed 2-hours following injury, microglia can be seen clustering together in direct 
contact with one another. While this is highly uncommon among ramified resting 
microglia, it has been observed in activated microglia. At 3-months post injury the 
microglia in the cortex have much larger cellular bodies than age matched controls.  
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Figure	  6.	  Activated	  microglia	  in	  the	  dentate	  gyrus	  of	  the	  hippocampus.	  An	  increase	  in	  the	  number	  of	  microglia	   can	  be	   seen	   in	   the	   (B)	  2-­‐hour	   rmTBI	   over	   the	   (A)	  2-­‐hour	   control	  mouse.	   (D)	  3-­‐month	  rmTBI	  microglia	  exhibit	  distinct	  changes	  to	  morphology	  with	  large	  cell	  bodies	  and	  thick	  cell	  processes	  as	  compared	  to	  age	  matched	  control	  (C)	  
Figure	   5.	   Lateral	   Ventricle	   microglial	   expression.	   Activated	   microglia	   express	   Iba1.	   rmTBI	  microglia	  show	  larger	  cell	  bodies	  and	  thicker	  cell	  processes	  in	  rmTBI	  (B)	  2-­‐hours	  post	  injury	  and	  
(D)	  3-­‐month	  post	  injury	  mice.	  Control	  mice	  (A	  and	  C)	  appear	  similar	  to	  one	  another.	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Figure	  7.	  Corpus	  callosum	  expression	  of	  activated	  microglia.	  More	  activated	  microglia	  are	  apparent	  in	  the	  (B)	  2-­‐hour	  rmTBI	  mouse	  than	  the	  (A)	  control	  2-­‐hour	  mouse.	  (D)	  at	  3-­‐months	  post	  rmTBI	  microglia	  remain	  in	  an	  activated	  morphology	  compared	  to	  age	  matched	  control	  (C).	  	  
Figure	   8.	   Cortex	   expression	   of	   activated	  microglia.	   Activated	  microglia	   express	   Iba1.	   The	  dotted	  box	  in	  (B)	  surrounds	  clustering	  activated	  microglia.	  (D)	  3-­‐months	  after	  rmTBI	  microglia	  remain	  activated	   in	   the	  cortex	  with	   large	  cell	  bodies	  compared	   to	   those	  seen	   in	  age	  matched	  controls	  (C).	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Discussion  
The objective of our rmTBI mouse study was initially to identify changes in 
ventricular volume following repeated head injury. We hypothesize that alteration in 
ventricular size or ependymal integrity could have negative implications for the SVZ stem 
cell niche that lies along the lateral wall of the lateral ventricles. Stretching of the lateral 
ventricles can lead to ependymal cell tearing, inducing glial scarring along the lateral wall 
[28]. Glial scaring along this region may compromise the brains ability to remove toxic 
molecules from the parenchyma into the CSF, exacerbating neurodegeneration and 
possibly increasing neuroinflammation.   The data from our ventricular tracing experiment 
shows that following rmTBI lateral ventricular volume gradually increases over 3-months. 
While we were unsurprised that there was expansion of the ventricles immediately 
following rmTBI, as this is seen in human TBI patients, we did not expect the expansion to 
continue throughout the entire 3-month period. This suggests that physicians caring for 
rmTBI patients should play close attention to alterations in ventricular volume and size as 
changes could have effects on global neuronal health and recovery. As the SVZ lies 
directly along the lateral ventricles neurogenesis may also be impaired by glial scaring and 
ventriculomegaly reducing the capacity for regeneration.  
 After observing a gradual increase in ventricular volume over 3-months in our 
initial rmTBI mouse model study, we moved our focus towards the neuroinflammatory 
process associated with rmTBI. We aimed to characterize microglial activation following 
rmTBI using confocal microscopy. Our rmTBI mouse model, designed by Kane et al., was 
specifically selected for its accurate replication of the rapid acceleration and deceleration 
of the brain that commonly occurs in human rmTBI, such as in a sports concussion. These 
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forces along with torsional rotation of the brain within the skull are thought to contribute to 
the primary mechanical injuries of rmTBI including tearing and damage to axons, cell 
bodies and neuronal networks. The leaking of intracellular molecules such as 
neurotransmitters and reactive oxygen species into the extracellular space induces 
secondary injury, leading to neuroinflammation and prolonged rmTBI symptoms. The 
activation of microglia is known to play a central role in the neuroinflammatory pathway, 
with M1 activated subtypes releasing pro-inflammatory cytokines and M2 microglia 
counterbalancing by releasing anti-inflammatory molecules into the brain [7] and [8].   
To gain a better understanding of the distribution of microglia throughout the brain 
following rmTBI and the timeline of activation, we examined microglia in four different 
brain regions: the lateral wall of the lateral ventricle, the hippocampus, the corpus callosum 
and the cortex. We found that 2-hours after rmTBI noticeable changes in microglial 
morphology could be observed in the lateral ventricle wall, the corpus callosum and cortex. 
Cell processes were thicker and cell bodies increased in size. At 3-months following 
rmTBI all experimental mice showed increased microglial activation over age-matched 
controls. The hippocampus showed the greatest microglial activation compared to age 
matched control. Observing microglia in an activated state 3-months following rmTBI 
indicates the inflammatory process persists long after injury. If the activated microglia are 
remaining in an M1 subtype, pro-inflammatory cytokines such as IL-1β that retard 
recovery and promote rmTBI symptoms may still be modulating the brains environment 
[7]. Recently, Fenn et al. showed mice with induced mTBI respond by releasing 
significantly more pro-inflammatory molecules when challenged with an IP 
lipopolysaccharide (LPS) injection, 30-days after mTBI injury, over control sham mice. 
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Following the LPS injection, mTBI mice took much longer to return to their baseline 
behavioral scores than control mice [7]. This study along with our own research indicates 
that prolonged microglial activation can occur following rmTBI, and that the activated 
microglia can prevent the brain from effectively responding to infection or injury for a 
significant period of time following rmTBI. Further studies on the M1/M2 subtypes of 
microglia present in the brain following rmTBI may be helpful in elucidating the 
neuroinflammatory pathways and generating timelines for therapeutics.  
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